Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Psychiatry and Clinical Neurosciences|November 4, 2016
Estimated cognitive decline in patients with schizophrenia: A multicenter studyHaruo Fujino, Chika Sumiyoshi, Yuka Yasuda, et al.
Neuropsychopharmacology Reports|December 2, 2021
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation studyNorio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|March 11, 2021
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation studyShusuke Numata, Masahito Nakataki, Naomi Hasegawa, et al.
BMC Psychiatry|May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter studyToshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
BMC Psychiatry|June 28, 2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 6, 2026
Optimizing multi-site schizophrenia differentiation: MRI harmonization with 20 controls per scanner in a study of 3560 subjects across 15 MRI scannersNaoki Hashimoto, Kiyotaka Nemoto, Masaki Fukunaga, et al.
Neuropsychopharmacology Reports|July 1, 2020
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" projectKayo Ichihashi, Hikaru Hori, Naomi Hasegawa, et al.
The International Journal of Neuropsychopharmacology|June 20, 2022
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide StudyShinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 29, 2022
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" projectHitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, et al.
Pageof 11